Home › Funds › SR ONE CAPITAL MANAGEMENT, LP › OCS
SR ONE CAPITAL MANAGEMENT, LP position in OCS
OCULIS HOLDING AG · Health Care
SR ONE CAPITAL MANAGEMENT, LP reported holding 641,022 shares of OCS (OCULIS HOLDING AG) in its Q2 2026 13F filing — a position valued at US$8.9M, representing 0.86% of its reported portfolio and ranking #13 among its reported holdings. SR ONE CAPITAL MANAGEMENT, LP has disclosed OCS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SR ONE CAPITAL MANAGEMENT, LP's OCS position evolved
SR ONE CAPITAL MANAGEMENT, LP first disclosed a stake in OCS in Q1 2025 at 322,500 shares (US$6.1M). The position peaked in Q1 2026 at 641,022 shares, worth US$17.0M. Across 6 filings, SR ONE CAPITAL MANAGEMENT, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 641,022 shares valued at US$8.9M. Notable position changes include a 99% increase in Q4 2025 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 322.50K | $6.14M | New |
| Q2 2025 | 322.50K | $6.26M | Hold |
| Q3 2025 | 322.50K | $5.67M | Hold |
| Q4 2025 | 641.02K | $12.80M | Add |
| Q1 2026 | 641.02K | $17.04M | Hold |
| Q2 2026 | 641.02K | $8.89M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OCS and 13F data
OCS (OCULIS HOLDING AG) is a Health Care company. 64 other funds we track also report a position in OCS — the largest reported positions include EQT Fund Management S.a r.l. (US$96.4M), Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$20.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OCS
- EQT Fund Management S.a r.l. 6.95M sh · $96.40M · Q2 2026
- Gildi - lifeyrissjodur 2.43M sh · $64.32M · Q1 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.51M sh · $20.89M · Q2 2026
- Saturn V Capital Management LP 684.88K sh · $9.50M · Q2 2026
- SYQUANT CAPITAL SAS 375.00K sh · $5.20M · Q2 2026
- Nan Fung Group Holdings Ltd 300.56K sh · $4.17M · Q2 2026
- Marble Bar Asset Management LLP 14.81K sh · $205.36K · Q2 2026
- DUPONT CAPITAL MANAGEMENT CORP 4 sh · $55.00K · Q2 2026
More on SR ONE CAPITAL MANAGEMENT, LP
FAQ
How long has SR ONE CAPITAL MANAGEMENT, LP held OCS?
SR ONE CAPITAL MANAGEMENT, LP has disclosed OCS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is SR ONE CAPITAL MANAGEMENT, LP's current position in OCS?
As of Q2 2026, SR ONE CAPITAL MANAGEMENT, LP holds 641.02K shares of OCS (OCULIS HOLDING AG), valued at $8.89M, representing 0.86% of its reported portfolio and ranking #13.
Has SR ONE CAPITAL MANAGEMENT, LP been buying or selling OCS?
In the latest 13F filing (Q2 2026), SR ONE CAPITAL MANAGEMENT, LP held unchanged its position in OCS. The position peaked in Q1 2026 at 641.02K shares.
Which other funds hold OCS?
Other major institutional holders of OCS include EQT Fund Management S.a r.l., Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.